The Need for Respiratory Syncytial Virus (RSV) Vaccine Research
Respiratory syncytial virus (RSV) can cause infections of the lungs and respiratory tract. Symptoms can be similar to a cold, and may include runny nose, sore throat, cough, and headache. RSV can lead to serious conditions like pneumonia, especially for children and seniors. In fact, RSV is the leading cause of pneumonia and bronchiolitis in infants in the United States.
There are currently no approved vaccines for RSV. However, many promising RSV vaccine candidates are in clinical trials. A safe and effective vaccine could save many lives and prevent a significant number of hospitalizations.
Velocity Clinical Research has supported RSV vaccine studies for more than a decade, and frequently conducts RSV vaccine studies for children, seniors, and even pregnant women.
How to Participate in an RSV Vaccine Trial
Velocity has research sites nationwide that are conducting clinical trials in a wide range of therapeutic areas. New studies are added every week. You can help fight RSV by joining a clinical trial at Velocity.
Beyond helping advance medicine, you may also:
- Learn about potential new medicines in development
- Get study-related medical exams at no cost
- Receive compensation for participating (available amounts may differ for each study)
The best way to find out which RSV studies are currently enrolling patients in your community and determine your eligibility is to complete the form on this page or call Velocity to speak with an enrollment specialist.
After you submit your information, a Velocity enrollment specialist will contact you. Together, we’ll review studies that might be right for you and answer your questions.
Health insurance is NOT required to join. There is never an obligation to participate — we’re here to help you make the best decision.
For more information about currently enrolling RSV studies, complete the form on this page or select a location below to get in touch with a Velocity enrollment specialist.